Trans-N-Fmoc-1,4-cyclohexanediamine hydrochloride is a protected diamine derivative featuring a trans-cyclohexane backbone. The molecule contains a primary amine group protected by a 9-fluorenylmethoxycarbonyl (Fmoc) group, while the other primary amine is present as a hydrochloride salt. This bifunctional structure makes it a versatile chiral building block. Its primary application is in the field of peptide and peptidomimetic synthesis, particularly in solid-phase peptide synthesis (SPPS) using the Fmoc strategy. The rigid, trans-cyclohexane diamine scaffold is incorporated into peptide sequences to induce specific conformational constraints, modulate physicochemical properties, or serve as a linker. It is also utilized in the synthesis of macrocyclic compounds and as a precursor for various bioactive molecules and pharmaceutical intermediates. The compound is a valuable synthetic intermediate in medicinal chemistry for constructing molecules with potential therapeutic applications. It is typically handled under standard laboratory conditions, and its stability and solubility profile are suitable for common organic synthesis protocols.